1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To describe the real-world clinical use of ceftolozane/tazobactam (C/T) and associated outcomes in France.

          Related collections

          Author and article information

          Journal
          Infect Dis Now
          Infectious diseases now
          Elsevier BV
          2666-9919
          2666-9919
          Sep 2021
          : 51
          : 6
          Affiliations
          [1 ] Service de maladies infectieuses, CH Périgueux, 80, Avenue Georges-Pompidou, Périgueux, France.
          [2 ] MSD France, 10-12, Cours Michelet, Puteaux, France.
          [3 ] ClinSearch, 110, Avenue Pierre Brossolette, Malakoff, France. Electronic address: anna.amode@clinsearch.net.
          [4 ] Unité Fonctionnelle de Conseil en Antibiothérapie, CHU Mulhouse, 87, avenue d'Altkirch, Mulhouse, France.
          [5 ] Laboratoire médicale, CHU de Nice, 30, Voie Romaine, Nice, France.
          [6 ] ClinSearch, 110, Avenue Pierre Brossolette, Malakoff, France.
          [7 ] Réanimation médicale et infectieuse, AP-HP Bichat, 46, Rue Henri-Huchard, Paris, France.
          [8 ] Unité maladies infectieuses et tropicales, CHU de Nantes, 1, Place Alexis-Ricordeau, Nantes, France.
          Article
          S2666-9919(21)00111-1
          10.1016/j.idnow.2021.05.003
          34015539
          7e310a58-f21f-4308-a824-9f16cc9b74c8
          History

          Pseudomonas aeruginosa,Antibiotic resistance,Ceftolozane/tazobactam,ESBL

          Comments

          Comment on this article